ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00000870
Brief Title: A Phase II Study of Intermittent Recombinant Human Interleukin-2 (rhIL-2) by Intravenous or Subcutaneous Administration in Subjects With HIV Infection on Highly Active Antiretroviral Therapy (HAART) Compared to HAART Alone

First Submitted : November 2, 1999
First Submitted that Met QC Criteria : August 30, 2001
First Posted : August 31, 2001 (Estimate)

Last Update Submitted that Met QC Criteria : May 17, 2012
Last Update Posted : May 21, 2012 (Estimate)